506 related articles for article (PubMed ID: 29926738)
21. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
[TBL] [Abstract][Full Text] [Related]
22. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
[TBL] [Abstract][Full Text] [Related]
23. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.
Moal V; Motte A; Vacher-Coponat H; Tamalet C; Berland Y; Colson P
J Clin Virol; 2015 Jul; 68():32-6. PubMed ID: 26071332
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
[TBL] [Abstract][Full Text] [Related]
25. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
26. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
[TBL] [Abstract][Full Text] [Related]
27. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
[TBL] [Abstract][Full Text] [Related]
28. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus vaccination in HIV-infected people: A review.
Catherine FX; Piroth L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28267387
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.
Farooq PD; Sherman KE
Curr HIV/AIDS Rep; 2019 Oct; 16(5):395-403. PubMed ID: 31468298
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.
Lô G; Sow-Sall A; Diop-Ndiaye H; Babacar N; Diouf NN; Daffé SM; Ndao B; Thiam M; Mbow M; Soumboundou MB; Lemoine M; Sylla-Niang M; Ndiaye O; Boye CS; Mboup S; Touré-Kane NC
Pan Afr Med J; 2019; 32():140. PubMed ID: 31303913
[TBL] [Abstract][Full Text] [Related]
32. Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo.
Shindano TA; Mbusa RK; Kabamba BM; Fiasse R; Horsmans Y
S Afr Med J; 2019 Apr; 109(5):319-322. PubMed ID: 31131798
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
35. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
[TBL] [Abstract][Full Text] [Related]
36. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
37. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
39. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
Halperin SA; Ward B; Cooper C; Predy G; Diaz-Mitoma F; Dionne M; Embree J; McGeer A; Zickler P; Moltz KH; Martz R; Meyer I; McNeil S; Langley JM; Martins E; Heyward WL; Martin JT
Vaccine; 2012 Mar; 30(15):2556-63. PubMed ID: 22326642
[TBL] [Abstract][Full Text] [Related]
40. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
